Intuitive Surgical, Inc. $ISRG Shares Acquired by V Square Quantitative Management LLC

Key Points

• V Square Quantitative Management LLC increased its stake in Intuitive Surgical, Inc. by 31.6%, owning 4,873 shares valued at approximately $2.65 million as of the last reporting period.
• Recent earnings showed Intuitive Surgical reported an EPS of $2.19, exceeding analysts' expectations, with revenues reaching $2.44 billion, a 21.4% increase year-over-year.
• Institutional investors own around 83.64% of Intuitive Surgical's stocks, contributing to a significant market capitalization of $158.13 billion.

V Square Quantitative Management LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 31.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,873 shares of the medical equipment provider's stock after acquiring an additional 1,170 shares during the quarter. V Square Quantitative Management LLC's holdings in Intuitive Surgical were worth $2,648,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Chilton Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. TD Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Evercore ISI upped their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. UBS Group upped their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. Finally, Wall Street Zen downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Friday. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $441.12 on Monday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business has a fifty day moving average of $469.43 and a two-hundred day moving average of $501.66. The company has a market cap of $158.13 billion, a P/E ratio of 61.52, a price-to-earnings-growth ratio of 4.62 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the company earned $1.78 earnings per share. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the firm's stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company's stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.